Hi jastigerfanA disastrous year. Depends on perspective. If you bought at 12 and sold at 1.5. then yep.
The captain has plenty of skin in the game and a proven track record.
I agree the printer side of things did not go as well as planned.
I think the purchase of stemify is a smart move.
The addition of 11 states.came about from the work of robo. ie they already had a foot in the door.
And i believe more contracts will follow. I also believe robo will be the preferred printer to go with the sale
of the stem kits.For me the poor share price is a buying opportunity. My brk even is 3.5 so still out of the money.
But quietly confident. Not a recommendation. just my take on it. each to there own.
cheers. enjoy the day.
- Forums
- ASX - By Stock
- SF1
- 2019 New chapter
2019 New chapter, page-4
-
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SF1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online